Carvedilol Phosphate
Pricing Report NDC 60505-3679-3

Latest NADAC: $5.07452 per EA · Effective Sep 20, 2023 · Est. package price $152.24 (30 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Carvedilol Phosphate (NDC 60505-3679-3) is $5.07452 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 20, 2023.

As a provided by Apotex Corp., this medication is distributed in a 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$5.07452
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Sep 20, 2023
Billable Units
30 EA
Estimated Package Price
$152.24
Data Status
As of Sep 27, 2023
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
60505-3679-3
Description
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jan 2018, the NADAC wholesale price for (NDC ) has moved within a range of $4.70357 to $7.12819 per EA. Over this 5 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$4.7036 - $7.1282
Market Volatility
51.55% Variance
Latest Trend
0.80%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 20, 2023 $5.07452 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 23, 2023 $5.03402 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 19, 2023 $5.22940 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 21, 2023 $4.83879 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 17, 2023 $5.53425 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 19, 2023 $5.43237 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 22, 2023 $5.72204 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 22, 2023 $5.17816 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 18, 2023 $4.90226 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 21, 2022 $5.75292 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 23, 2022 $5.34073 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 19, 2022 $4.70357 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026